Antibodies to oncostatin M receptor
US7572896B2 · kind B2 · utility
16Cited by
24References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2006 |
| Grant date | Aug 11, 2009 |
| Priority date | — |
| Expiry date | Oct 23, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/715
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides characterization of the disease and cancer-associated antigen, OSM-R.beta. The invention also provides modulators of OSM-R.beta, including a family of monoclonal antibodies that bind to antigen OSM-R.beta, and methods of diagnosing and treating various human cancers and diseases associated with OSM-R.beta.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.